HIV / AIDS in the News

South African Indian-origin couple receive prestigious US prize for HIV/AIDS research - The Times of India

 

Pharma firms eye growth with HIV long-acting treatments: HSBC - Investing.com

 

Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment - Journal of Translational Medicine

 

NIH Grant Funds Novel Test-to-PrEP, HIV Outreach Strategies - University of Miami

 

5 Decades of Notable Achievements in Treatment for HIV/AIDS - AJMC.com Managed Markets Network

 

NATIONAL Eric Adams, History Month event, HIV awareness, lesbian bar - Windy City Times

 

HIV cure: ending the HIV epidemic - ViiV Healthcare

 

MAGA influencers spread lie claiming Pete Buttigieg is HIV-positive - LGBTQ Nation

 

Predicting Changes in the HIV Reservoir - amfAR, The Foundation for AIDS Research

 

HIV/STI, Viral Hepatitis Prevention - Houston Health Department

 

Data Table: Monitoring National HIV Prevention Goals - CDC

 

World AIDS Day 2024: Collective Action: Sustain and Accelerate HIV Progress - HIV.gov

 

Gilead's tie up with generic cos may not address HIV challenge - The Times of India

 

Gilead Makes Generic HIV Drug Plan, Advocates Urge Expansion - Law360

 

Conservatives push harmful lie that Pete Buttigieg is HIV-positive​ - Advocate.com

 

Pants on Fire claim about Secretary Pete Buttigieg and HIV - PolitiFact

 

HIV Alliance announces launch of The Lavender Network - nbc16.com

 

HIV Alliance announces launch of The Lavender Network - KVAL

 

HIV Alliance announces launch of The Lavender Network - nbc16.com

 

Addressing HIV Disparities in Native American Communities - The University of New Mexico

 

The Wistar Institute and University of Pennsylvania - GlobeNewswire

 

AIDS Walk Northwest Raises Nearly $259K for HIV Advocacy - POZ

 

Biopharma firm Gilead announces lenacapavir licensing for HIV treatment - The Indian Express

 

Biopharma firm Gilead announces lenacapavir licensing for HIV treatment - The Indian Express

 

HIV is back; there has been a 30% surge in 2 years; is it that fatal now? - The Economic Times

 

Brain abscess caused by Nocardia farcinica in a person living with HIV - BMC Infectious Diseases

 

Bottleneck breakthrough - Fred Hutchinson Cancer Center

 

GILD Grants Right for HIV PrEP Candidate to Six Generic Companies - Yahoo Finance

 

GILD Grants Right for HIV PrEP Candidate to Six Generic Companies - Zacks Investment Research

 

Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application - BusinessLine